Protia (A303360) Stock Overview
Manufactures and sells in vitro diagnostic medical devices in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
A303360 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Protia Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,115.00 |
| 52 Week High | ₩6,890.00 |
| 52 Week Low | ₩2,935.00 |
| Beta | 0.27 |
| 1 Month Change | -14.63% |
| 3 Month Change | -18.35% |
| 1 Year Change | 23.95% |
| 3 Year Change | -18.51% |
| 5 Year Change | -46.14% |
| Change since IPO | -54.28% |
Recent News & Updates
Protia's (KOSDAQ:303360) Promising Earnings May Rest On Soft Foundations
Despite posting some strong earnings, the market for Protia Inc.'s ( KOSDAQ:303360 ) stock hasn't moved much. Our...Investors Will Want Protia's (KOSDAQ:303360) Growth In ROCE To Persist
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...Subdued Growth No Barrier To Protia Inc. (KOSDAQ:303360) With Shares Advancing 35%
Protia Inc. ( KOSDAQ:303360 ) shareholders have had their patience rewarded with a 35% share price jump in the last...Recent updates
Shareholder Returns
| A303360 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 3.5% | -4.8% | -7.9% |
| 1Y | 23.9% | -17.2% | 164.6% |
Return vs Industry: A303360 exceeded the KR Medical Equipment industry which returned -17.2% over the past year.
Return vs Market: A303360 underperformed the KR Market which returned 164.6% over the past year.
Price Volatility
| A303360 volatility | |
|---|---|
| A303360 Average Weekly Movement | 5.6% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in KR Market | 15.9% |
| 10% least volatile stocks in KR Market | 4.4% |
Stable Share Price: A303360 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A303360's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Kook Jin Lim | www.protia.co.kr |
Protia Inc. manufactures and sells in vitro diagnostic medical devices in South Korea. It offers allergy, animal diagnosis, autoimmune, antibiotic susceptibility, POCT, cancer, and related instrument products, as well as protein analysis, LC-MS/MS, characterization analysis, and custom protein services. The company was formerly known as ProteomeTech Inc. and changed its name to Protia Inc. in November 2023.
Protia Inc. Fundamentals Summary
| A303360 fundamental statistics | |
|---|---|
| Market cap | ₩53.00b |
| Earnings (TTM) | ₩4.74b |
| Revenue (TTM) | ₩16.25b |
Is A303360 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A303360 income statement (TTM) | |
|---|---|
| Revenue | ₩16.25b |
| Cost of Revenue | ₩6.27b |
| Gross Profit | ₩9.98b |
| Other Expenses | ₩5.24b |
| Earnings | ₩4.74b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 367.66 |
| Gross Margin | 61.42% |
| Net Profit Margin | 29.15% |
| Debt/Equity Ratio | 0% |
How did A303360 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/10 21:26 |
| End of Day Share Price | 2026/06/10 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Protia Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.